May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Arndt Vogel Highlights Advances and Challenges in HER2-Targeted Therapies for Colorectal Cancer
Apr 28, 2025, 08:02

Arndt Vogel Highlights Advances and Challenges in HER2-Targeted Therapies for Colorectal Cancer

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology at Hannover Medical School, shared on X:

“Advances and challenges in targeted therapies for HER2-amplified CRC, European J Cancer.

  • Excellent review HER2
  • overexpressed in ~6% of RAS WT
  • Trastuzumab/Tucatinib and T-Deruxtecan FDA approved , but still many open questions.”

Arndt Vogel Highlights Advances and Challenges in HER2-Targeted Therapies for Colorectal Cancer

Advances and challenges in targeted therapies for HER2-amplified colorectal cancer

Authors: Margot Pizzamiglio et al.

Arndt Vogel Highlights Advances and Challenges in HER2-Targeted Therapies for Colorectal Cancer

More posts featuring Arndt Vogel on OncoDaily.